Correction: CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC
Tirado-Gonzalez, I, Czlonka, E, Nevmerzhitskaya, A, Soetopo, D, Bergonzani, E, Mahmoud, A, Contreras, A, Jeremias, I, Platzbecker, U, Bourquin, J P, Kloz, U, Van der Hoeven, F, Medyouf, H
Published in Leukemia (01.01.2021)
Published in Leukemia (01.01.2021)
Get full text
Journal Article
The identification of the AXL/Gas6 signalling axis as a key player of myelodysplastic syndrome (MDS) and the potential of the oral selective AXL inhibitor bemcentinib in the treatment of MDS
Medyouf, H., Tirado-Gonzalez, I., Mies, A., Nevmerzhitskaya, A., Kubasch, A.-S., Platzbecker, U.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
CD15 – A new marker of pathological villous immaturity of the term placenta
Seidmann, L, Suhan, T, Kamyshanskiy, Y, Nevmerzhitskaya, A, Gerein, V, Kirkpatrick, C.J
Published in Placenta (Eastbourne) (01.11.2014)
Published in Placenta (Eastbourne) (01.11.2014)
Get full text
Journal Article
CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC
Tirado-Gonzalez, I, Czlonka, E, Nevmerzhitskaya, A, Soetopo, D, Bergonzani, E, Mahmoud, A, Contreras, A, Jeremias, I, Platzbecker, U, Bourquin, J P, Kloz, U, Van der Hoeven, F, Medyouf, H
Published in Leukemia (01.04.2018)
Published in Leukemia (01.04.2018)
Get full text
Journal Article
1009PDThe identification of the AXL/Gas6 signalling axis as a key player of myelodysplastic syndrome (MDS) and the potential of the oral selective AXL inhibitor bemcentinib in the treatment of MDS
Medyouf, H, Tirado-Gonzalez, I, Mies, A, Nevmerzhitskaya, A, Kubasch, A-S, Platzbecker, U
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article